期刊文献+

雷米普利与非洛地平对高血压拌左室肥厚患者疗效的对比研究

Comparison of the effects bewteen ramipril and felodipine in patients with hypertensive left ventricular hypertrophy
下载PDF
导出
摘要 目的比较雷米普利与非洛地平对高血压患者左室肥厚的疗效。方法 93例高血压拌左室肥厚患者随机接受雷米普利(47例,雷米普利组)或非洛地平(46例,非洛地平组)治疗,随访治疗6个月后复查左室重量和左室重量指数。结果用药后两组高血压患者左室重量和左室重量指数均显示有意义的减少[雷米普利组LVM:(244.3±5.4)g和(207.7±3.5)g,LVMI:(131±5)g/m2和(114±4)g/m2,P均﹤0.01;非洛地平组LVM:(250.0±4.2)g和(237.5±4.2)g,LVMI:(136±4)g/m2和(131±3)g/m2,P均﹤0.05];与非洛地平组比较,雷米普利组左室重量和左室重量指数降低更明显[LVM:(244.3±5.4)g和(237.5±4.2)g;LVMI:(131±5)g/m2和(131±3)g/m2,P均﹤0.01]。结论雷米普利能够逆转高血压患者的左室肥厚,且优于非洛地平。 Objective To compare the effects of ramipril and felodipine in patients with hypertensive left ventricular hypertrophy. Methods 93 patients with hypertensive were randommized to receive ramipril (Group A, 47 cases)and felodipine(Group B, 46 cases). The left ventricular mass (LVM)and the left ventricular mass index(LVMI)after 6 months of treatment were compared between the two groups. Results In group A, the LVM and the LVMI were significantly decreasedP0.01], in group B, the LVM and LVMI were significantly decreased P0.05]at 6 months later. Compared with groupB, the LVM and the LVMI of group A were much lowerP0.01],Conclusion Ramipril may exert a better effect than felodipine in patients with hypertensive left ventrcular hypertrophy.
作者 扈敏
机构地区 郑州大学医院
出处 《中国实用医药》 2013年第7期46-47,共2页 China Practical Medicine
关键词 雷米普利 非洛地平 高血压 左室肥厚 Ramipril Felodipine Hypertension Left ventrcular hypertrophy
  • 相关文献

参考文献9

  • 1Zanchetti A.Goals of antihypertensive treatment:Prevention of cardiovascular events and prevention of organ damage.Blood Press,1999,1:201-211.
  • 2张维忠,邱慧丽,范明昌,龚兰生.高血压左心室肥厚的诊断探讨——5437例超声心动图资料分析[J].中国高血压杂志,1993,1(1):5-8. 被引量:87
  • 3Reickeck N,DevereuxRB.Reliable estimation of peak left ventricnlar systolic pressure by m-mode echographic-determined end-diastolic relative wall thichness:identificaticn of severe valular aortic stenonsis in adult patients.AM Heart J,2005,103:202-203.
  • 4Casale,PN Devereux RB,Milner M,et al.Value of echocardiographie measurment of ventricular mass in predicting cardiovascular morbid events in bypentensive men.Ann Intern Med,2003,105:177-178.
  • 5Muiesan ML,SalvettiM,RizzonniD,et al.Association of change in left ventricular mass with prognosis during long-term antihypertensive treatmemt.J Hypertens,2007,13:1091-1095.
  • 6Eichsfaedt H,Danne O,langen M,et al.Regrission of left ventricular hypertrophy under Ramipril trentment invesinvestigated by nuclear magnetic resonane imagine.J Cardionvase Pharmacol,2006,13(suppl3):75-78.
  • 7Lievre M,GueretP,GayetC,et al.On behalf of the HYCAR study Gmup:Ramipril-induced regression of left ventricular hypertrophy in treated hypetensive individuals.Hypertension,2005,25:92-96.
  • 8Cruickshank JM,Lewise J,MooreV,et al.Reversibility of left ventricular hypertrophy by differing type of antihypertensive therapy.J Hum Hypertens,1992,6:85-90.
  • 9Otterstad JE,Foreland G,Wasenius Soeyland A K,et al.Changs in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year,s treatment with atenll vs hydrochlorothiazide and amiloride (Modurelic):a double blind,randomized study.J Intern Med,2006,231:493-501.

共引文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部